Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Filter Contract Award

20 Dec 2011 09:45

RNS Number : 3098U
Avon Rubber PLC
20 December 2011
 



20 December 2011

FILTER CONTRACT AWARD

Avon is pleased to announce that it has received a 5 year contract from the Department of Defense (DoD) for the supply of spare filters for its M50 respirator. Like previous contracts for spare filters, the contract is an Indefinite Delivery Indefinite Quantity ("IDIQ") contract and has a maximum order quantity of 2.4m filter pairs per year and 12m filter pairs over the contract term. The contract also allows the DoD to extend the term by 2 further option years, potentially extending the duration to 7 years. An initial order has been placed by the DoD with a value of $2.5m for immediate delivery.

This new contract is in addition to the existing sole source $38m, 3 year IDIQ contract announced in August. Avon has also received a further delivery order against this contact with a value of $6.1m for delivery by 1 April 2012.

As expected, the DoD has chosen to dual source the procurement of spare filters and another source has also been selected for a 5 year contract award. The Directors believe that it will take up to 2 years for a comparable product to be developed and approved, after which orders for filters for the M50 mask will be competitively bid. The supply of filters with M50 mask systems will remain sole sourced to Avon.

Commenting on the news, Peter Slabbert, Chief Executive said: "We are delighted to have been awarded this new contract which confirms Avon's position as a supplier of consumable filters to the DoD for a further 5 to 7 years. The procurement of the filter for the M50 mask from another supplier was expected and we believe that our state of the art manufacturing capability, our existing technology advantage and the continuation of the sole source window for up to another 2 years will allow Avon to retain its competitive advantage. We are also committed to widening our capability and product range in the area of filtration to enable us to continue to grow this repeat revenue stream."

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896 870

Andrew Lewis, Group Finance Director

01225 896 830

Fiona Stewart, Corporate Communications Executive

01225 896 871

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder, emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and tubing for the automated milking process. For further information please visit the Group's website www.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGCBDDRDDBGBG
Date   Source Headline
6th Sep 20139:07 amRNSDirector/PDMR Shareholding
6th Sep 20137:00 amRNSContract Award
29th Aug 20139:39 amRNSHolding(s) in Company
23rd Aug 20131:50 pmRNSDirector/PDMR Shareholding
22nd Aug 20138:48 amRNSHolding(s) in Company
16th Aug 20137:00 amRNSInterim Management Statement
6th Aug 20139:21 amRNSDirector/PDMR Shareholding
5th Aug 20137:01 amRNSContract Award
25th Jul 20131:43 pmRNSHolding(s) in Company
8th Jul 20139:24 amRNSDirector/PDMR Shareholding
4th Jul 201311:14 amRNSHolding(s) in Company
10th Jun 201310:51 amRNSDirector/PDMR Shareholding - SIP
10th May 20139:00 amRNSDirector/PDMR Shareholding - Replacement
8th May 20138:50 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSHalf Yearly Report
26th Apr 20137:00 amRNSAcquisition
5th Apr 20134:12 pmRNSDirector/PDMR Shareholding
6th Mar 20132:30 pmRNSDirector/PDMR Shareholding
7th Feb 20133:50 pmRNSResult of AGM and Retirement of Director
7th Feb 20137:00 amRNSInterim Management Statement
5th Feb 20134:23 pmRNSDirector/PDMR Shareholding
5th Feb 20139:26 amRNSHolding(s) in Company
8th Jan 201312:41 pmRNSDirector/PDMR Shareholding
18th Dec 201210:07 amRNSAnnual Financial Report
6th Dec 201210:28 amRNSDirector/PDMR Shareholding
5th Dec 20123:30 pmRNSDirectors and PDMRs Interest in Shares
5th Dec 20123:30 pmRNSEmployee Share Plans
21st Nov 20127:01 amRNSDirectorate Change
21st Nov 20127:00 amRNSFinal Results
6th Nov 20124:09 pmRNSDirector/PDMR Shareholding
11th Oct 20127:00 amRNSFull Year Trading Update
8th Oct 201212:28 pmRNSDirector/PDMR Shareholding
25th Sep 20121:38 pmRNSHolding(s) in Company
10th Sep 20122:31 pmRNSDirector/PDMR Shareholding
8th Aug 20127:00 amRNSInterim Management Statement
6th Aug 20122:16 pmRNSDirector/PDMR Shareholding
26th Jul 20129:30 amRNSDirector/PDMR Shareholding
6th Jul 201210:58 amRNSDirector/PDMR Shareholding
3rd Jul 201211:58 amRNSHolding(s) in Company
26th Apr 201210:00 amRNSHolding(s) in Company
20th Apr 20122:25 pmRNSHolding(s) in Company
19th Apr 201211:33 amRNSHolding(s) in Company
18th Apr 201212:00 pmRNSNotice of Results
14th Mar 201211:30 amRNSHolding(s) in Company
1st Mar 20124:42 pmRNSDirector/PDMR Shareholding
28th Feb 20127:00 amRNSFilter Contract Status Update
9th Feb 20122:10 pmRNSBlock Listing Cancellation
2nd Feb 20121:00 pmRNSResult of AGM
2nd Feb 20127:00 amRNSInterim Management Statement
12th Jan 20122:00 pmRNSAnnual Information Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.